SIMEPREVIR PLUS PEGINTERFERON/RIBAVIRIN COST-EFFECTIVENESS ANALYSIS FOR THE TREATMENT OF CHRONIC GENOTYPE 1 HEPATITIS C IN MEXICO

被引：0
|
作者：
Heibeck, V [1 ]
Westerhout, K. Y. [2 ]
Naciben, V [3 ]
Gasca-Pineda, R. [4 ]
Hernandez-Garduno, A. [5 ]
Chacon-Ramos, C. [4 ]
机构：
[1] Pharmerit Int, Berlin, Germany
[2] Pharmerit Int, Rotterdam, Netherlands
[3] Janssen Pharmaceut, Sao Paulo, Brazil
[4] Janssen Pharmaceut, Mexico City, DF, Mexico
[5] Janssen, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.018
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN24
引用
收藏
页码：A872 / A872
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [32] Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence
    Gimeno-Ballester, Vicente
    Angel Simon, Miguel
    Trigo, Cristina
    Mar, Javier
    San Miguel, Ramon
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (11) : 1289 - 1303
  • [33] Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
    Marciano, Sebastian
    Borzi, Silvia M.
    Dirchwolf, Melisa
    Ridruejo, Ezequiel
    Mendizabal, Manuel
    Bessone, Fernando
    Sirotinsky, Maria E.
    Giunta, Diego H.
    Trinks, Julieta
    Olivera, Pablo A.
    Galdame, Omar A.
    Silva, Marcelo O.
    Fainboim, Hugo A.
    Gadano, Adrian C.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (04) : 703 - 709
  • [34] Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4
    Khuroo, MS
    Khuroo, MS
    Dahab, ST
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (09) : 931 - 938
  • [35] Peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4: A meta-analysis of randomized trials
    Khuroo, MS
    Khuroo, MS
    Dahab, ST
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S100 - S100
  • [36] Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
    Sebastián Marciano
    Silvia M Borzi
    Melisa Dirchwolf
    Ezequiel Ridruejo
    Manuel Mendizabal
    Fernando Bessone
    María E Sirotinsky
    Diego H Giunta
    Julieta Trinks
    Pablo A Olivera
    Omar A Galdame
    Marcelo O Silva
    Hugo A Fainboim
    Adrián C Gadano
    [J]. World Journal of Hepatology, 2015, (04) : 703 - 709
  • [37] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir
    Ogurtsov, Pavel
    Lukyanova, Ekaterina
    Long, Jianmin
    Wah, Janice
    Helmond, Frans A.
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (06) : 331 - 339
  • [38] Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Al-Ajmi, M
    Owaid, S
    Varghese, R
    Al-Nakib, B
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1733 - 1737
  • [39] Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia
    Vasily Isakov
    Igor Nikitin
    Vladimir Chulanov
    Pavel Ogurtsov
    Ekaterina Lukyanova
    Jianmin Long
    Janice Wahl
    Frans A Helmond
    the P08160 trial Investigators
    [J]. World Journal of Hepatology, 2016, (06) : 331 - 339
  • [40] Results of treatment with peginterferon plus ribavirin in patients with chronic hepatitis C
    Pizarro, Carolina
    Venegas, Mauricio
    Hola, Karen
    Smok, Gladys
    Brahm, Javier
    [J]. REVISTA MEDICA DE CHILE, 2011, 139 (06) : 704 - 709
12345